Cumberland Pharmaceuticals Stock Market Value
| CPIX Stock | USD 3.88 0.09 2.37% |
| Symbol | Cumberland |
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cumberland Pharmaceuticals. Projected growth potential of Cumberland fundamentally drives upward valuation adjustments. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Cumberland Pharmaceuticals assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share (0.24) | Revenue Per Share | Quarterly Revenue Growth (0.09) | Return On Assets | Return On Equity |
Cumberland Pharmaceuticals's market price often diverges from its book value, the accounting figure shown on Cumberland's balance sheet. Smart investors calculate Cumberland Pharmaceuticals' intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Since Cumberland Pharmaceuticals' trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
It's important to distinguish between Cumberland Pharmaceuticals' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Cumberland Pharmaceuticals should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. However, Cumberland Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cumberland Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Cumberland Pharmaceuticals' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Cumberland Pharmaceuticals.
| 11/16/2025 |
| 02/14/2026 |
If you would invest 0.00 in Cumberland Pharmaceuticals on November 16, 2025 and sell it all today you would earn a total of 0.00 from holding Cumberland Pharmaceuticals or generate 0.0% return on investment in Cumberland Pharmaceuticals over 90 days. Cumberland Pharmaceuticals is related to or competes with Quantum BioPharma, Rockwell Medical, ABVC Biopharma, Lantern Pharma, Inotiv, CalciMedica Common, and Dyadic International. Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commer... More
Cumberland Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Cumberland Pharmaceuticals' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Cumberland Pharmaceuticals upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 4.45 | |||
| Information Ratio | 0.1889 | |||
| Maximum Drawdown | 29.09 | |||
| Value At Risk | (7.76) | |||
| Potential Upside | 12.6 |
Cumberland Pharmaceuticals Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Cumberland Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Cumberland Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Cumberland Pharmaceuticals historical prices to predict the future Cumberland Pharmaceuticals' volatility.| Risk Adjusted Performance | 0.1706 | |||
| Jensen Alpha | 1.1 | |||
| Total Risk Alpha | 0.7395 | |||
| Sortino Ratio | 0.2515 | |||
| Treynor Ratio | 0.8807 |
Cumberland Pharmaceuticals February 14, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1706 | |||
| Market Risk Adjusted Performance | 0.8907 | |||
| Mean Deviation | 4.2 | |||
| Semi Deviation | 3.72 | |||
| Downside Deviation | 4.45 | |||
| Coefficient Of Variation | 498.26 | |||
| Standard Deviation | 5.93 | |||
| Variance | 35.15 | |||
| Information Ratio | 0.1889 | |||
| Jensen Alpha | 1.1 | |||
| Total Risk Alpha | 0.7395 | |||
| Sortino Ratio | 0.2515 | |||
| Treynor Ratio | 0.8807 | |||
| Maximum Drawdown | 29.09 | |||
| Value At Risk | (7.76) | |||
| Potential Upside | 12.6 | |||
| Downside Variance | 19.84 | |||
| Semi Variance | 13.87 | |||
| Expected Short fall | (5.03) | |||
| Skewness | 1.05 | |||
| Kurtosis | 2.02 |
Cumberland Pharmaceuticals Backtested Returns
Cumberland Pharmaceuticals is unstable given 3 months investment horizon. Cumberland Pharmaceuticals secures Sharpe Ratio (or Efficiency) of 0.23, which signifies that the company had a 0.23 % return per unit of risk over the last 3 months. We were able to collect and analyze data for twenty-eight different technical indicators, which can help you to evaluate if expected returns of 1.34% are justified by taking the suggested risk. Use Cumberland Pharmaceuticals Mean Deviation of 4.2, risk adjusted performance of 0.1706, and Downside Deviation of 4.45 to evaluate company specific risk that cannot be diversified away. Cumberland Pharmaceuticals holds a performance score of 17 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of 1.34, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Cumberland Pharmaceuticals will likely underperform. Use Cumberland Pharmaceuticals treynor ratio, as well as the relationship between the expected short fall and day median price , to analyze future returns on Cumberland Pharmaceuticals.
Auto-correlation | -0.62 |
Very good reverse predictability
Cumberland Pharmaceuticals has very good reverse predictability. Overlapping area represents the amount of predictability between Cumberland Pharmaceuticals time series from 16th of November 2025 to 31st of December 2025 and 31st of December 2025 to 14th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Cumberland Pharmaceuticals price movement. The serial correlation of -0.62 indicates that roughly 62.0% of current Cumberland Pharmaceuticals price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.62 | |
| Spearman Rank Test | -0.69 | |
| Residual Average | 0.0 | |
| Price Variance | 0.21 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Cumberland Stock Analysis
When running Cumberland Pharmaceuticals' price analysis, check to measure Cumberland Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cumberland Pharmaceuticals is operating at the current time. Most of Cumberland Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Cumberland Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cumberland Pharmaceuticals' price. Additionally, you may evaluate how the addition of Cumberland Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.